Given recent reports demonstrating that nanoscale liposomes targeting E-selectin ligands on circulating cancer cells may lead to better patient outcomes (36, 37), there is a greater need to understand fundamental selectin/selectin-ligand mediated cancer cell adhesion during metastasis. Here, SELE is linked to cancer.